Home LiteratureArticle Details
PMID: 28650482 Published · ppublish English Journal Article Meta-Analysis

The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability.

Nature genetics ·Vol. 49 ·No. 8 ·2017-08-00 ·Pages 1167-1173

Singh T, Walters JTR, Johnstone M, Curtis D, Suvisaari J, Torniainen M, Rees E, Iyegbe C, Blackwood D, McIntosh AM, Kirov G, Geschwind D, Murray RM, Di Forti M, Bramon E, Gandal M, Hultman CM, Sklar P, INTERVAL Study, UK10K Consortium, Palotie A, Sullivan PF, O'Donovan MC, Owen MJ, Barrett JC

Abstract

By performing a meta-analysis of rare coding variants in whole-exome sequences from 4,133 schizophrenia cases and 9,274 controls, de novo mutations in 1,077 family trios, and copy number variants from 6,882 cases and 11,255 controls, we show that individuals with schizophrenia carry a significant burden of rare, damaging variants in 3,488 genes previously identified as having a near-complete depletion of loss-of-function variants. In patients with schizophrenia who also have intellectual disability, this burden is concentrated in risk genes associated with neurodevelopmental disorders. After excluding known risk genes for neurodevelopmental disorders, a significant rare variant burden persists in other genes intolerant of loss-of-function variants; although this effect is notably stronger in patients with both schizophrenia and intellectual disability, it is also seen in patients with schizophrenia who do not have intellectual disability. Together, our results show that rare, damaging variants contribute to the risk of schizophrenia both with and without intellectual disability and support an overlap of genetic risk between schizophrenia and other neurodevelopmental disorders.

MeSH Terms
Case-Control Studies Exome Genetic Predisposition to Disease Genetic Variation Genotyping Techniques Humans Intellectual Disability/genetics Mutation Neurodevelopmental Disorders/genetics Polymorphism, Single Nucleotide Schizophrenia/genetics,physiopathology Sequence Analysis, DNA
Authors & Affiliations
25 authors, click to expand affiliations / ORCID
Singh Tarjinder
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Walters James T R
MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
Johnstone Mandy ORCID
Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
Curtis David
University College London Genetics Institute, University College London, London, UK. | Centre for Psychiatry, Barts and the London School of Medicine and Dentistry, London, UK.
Suvisaari Jaana ORCID
National Institute for Health and Welfare, Helsinki, Finland.
Torniainen Minna
National Institute for Health and Welfare, Helsinki, Finland.
Rees Elliott
MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
Iyegbe Conrad
Institute of Psychiatry, King's College London, London, UK.
Blackwood Douglas ORCID
Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
McIntosh Andrew M ORCID
Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.
Kirov Georg
MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
Geschwind Daniel
Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Murray Robin M
Institute of Psychiatry, King's College London, London, UK.
Di Forti Marta
Institute of Psychiatry, King's College London, London, UK.
Bramon Elvira ORCID
Division of Psychiatry, University College London, London, UK.
Gandal Michael ORCID
Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Hultman Christina M
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Sklar Pamela
Division of Psychiatric Genomics, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
INTERVAL Study
UK10K Consortium
Palotie Aarno
Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland. | Program in Medical and Population Genetics and Genetic Analysis Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Sullivan Patrick F
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. | Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill, North Carolina, USA.
O'Donovan Michael C ORCID
MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
Owen Michael J ORCID
MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.
Barrett Jeffrey C ORCID
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
References (50)
50 references, click to expand
  1. 22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome.
    Am J Hum Genet. 2008 Jan;82(1):214-21 PMID: 18179902
  2. Rare chromosomal deletions and duplications increase risk of schizophrenia.
    Nature. 2008 Sep 11;455(7210):237-41 PMID: 18668038
  3. The dopamine hypothesis of schizophrenia: version III--the final common pathway.
    Schizophr Bull. 2009 May;35(3):549-62 PMID: 19325164
  4. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources.
    Am J Hum Genet. 2009 Apr;84(4):524-33 PMID: 19344873
  5. Schizophrenia.
    Lancet. 2009 Aug 22;374(9690):635-45 PMID: 19700006
  6. Pooled association tests for rare variants in exon-resequencing studies.
    Am J Hum Genet. 2010 Jun 11;86(6):832-8 PMID: 20471002
  7. Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function.
    PLoS Genet. 2010 Sep 09;6(9):e1001097 PMID: 20838587
  8. Neurodevelopmental hypothesis of schizophrenia.
    Br J Psychiatry. 2011 Mar;198(3):173-5 PMID: 21357874
  9. Increased exonic de novo mutation rate in individuals with schizophrenia.
    Nat Genet. 2011 Jul 10;43(9):860-3 PMID: 21743468
  10. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.
    Cell. 2011 Jul 22;146(2):247-61 PMID: 21784246
  11. Exome sequencing supports a de novo mutational paradigm for schizophrenia.
    Nat Genet. 2011 Aug 07;43(9):864-8 PMID: 21822266
  12. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.
    Mol Psychiatry. 2012 Feb;17(2):142-53 PMID: 22083728
  13. Neurodevelopmental model of schizophrenia: update 2012.
    Mol Psychiatry. 2012 Dec;17(12):1228-38 PMID: 22488257
  14. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia.
    Nat Genet. 2012 Dec;44(12):1365-9 PMID: 23042115
  15. FMRP targets distinct mRNA sequence elements to regulate protein expression.
    Nature. 2012 Dec 20;492(7429):382-6 PMID: 23235829
  16. Genotype-phenotype correlation in 22q11.2 deletion syndrome.
    BMC Med Genet. 2012 Dec 17;13:122 PMID: 23245648
  17. Definition and description of schizophrenia in the DSM-5.
    Schizophr Res. 2013 Oct;150(1):3-10 PMID: 23800613
  18. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.
    Nat Genet. 2013 Sep;45(9):984-94 PMID: 23933821
  19. The penetrance of copy number variations for schizophrenia and developmental delay.
    Biol Psychiatry. 2014 Mar 1;75(5):378-85 PMID: 23992924
  20. CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1.
    Hum Mol Genet. 2014 Mar 15;23(6):1669-76 PMID: 24163246
  21. Analysis of copy number variations at 15 schizophrenia-associated loci.
    Br J Psychiatry. 2014 Feb;204(2):108-14 PMID: 24311552
  22. De novo mutations in schizophrenia implicate synaptic networks.
    Nature. 2014 Feb 13;506(7487):179-84 PMID: 24463507
  23. A polygenic burden of rare disruptive mutations in schizophrenia.
    Nature. 2014 Feb 13;506(7487):185-90 PMID: 24463508
  24. A general framework for estimating the relative pathogenicity of human genetic variants.
    Nat Genet. 2014 Mar;46(3):310-5 PMID: 24487276
  25. Copy number variation in schizophrenia in Sweden.
    Mol Psychiatry. 2014 Jul;19(7):762-73 PMID: 24776740
  26. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability.
    Mol Psychiatry. 2014 Jun;19(6):652-8 PMID: 24776741
  27. Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene.
    Neuron. 2014 May 21;82(4):773-80 PMID: 24853937
  28. One gene, many neuropsychiatric disorders: lessons from Mendelian diseases.
    Nat Neurosci. 2014 Jun;17(6):773-81 PMID: 24866043
  29. Biological insights from 108 schizophrenia-associated genetic loci.
    Nature. 2014 Jul 24;511(7510):421-7 PMID: 25056061
  30. A framework for the interpretation of de novo mutation in human disease.
    Nat Genet. 2014 Sep;46(9):944-50 PMID: 25086666
  31. Synaptic, transcriptional and chromatin genes disrupted in autism.
    Nature. 2014 Nov 13;515(7526):209-15 PMID: 25363760
  32. The contribution of de novo coding mutations to autism spectrum disorder.
    Nature. 2014 Nov 13;515(7526):216-21 PMID: 25363768
  33. Exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genes.
    PLoS One. 2014 Nov 24;9(11):e112745 PMID: 25420024
  34. New approaches to psychiatric diagnostic classification.
    Neuron. 2014 Nov 5;84(3):564-71 PMID: 25442935
  35. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.
    Nature. 2015 Feb 5;518(7537):102-6 PMID: 25487149
  36. Large-scale discovery of novel genetic causes of developmental disorders.
    Nature. 2015 Mar 12;519(7542):223-8 PMID: 25533962
  37. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways.
    Nat Neurosci. 2015 Feb;18(2):199-209 PMID: 25599223
  38. The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment.
    Nat Commun. 2015 Mar 10;6:6404 PMID: 25752243
  39. Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia.
    Neuron. 2015 Jun 3;86(5):1203-14 PMID: 26050040
  40. Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci.
    Neuron. 2015 Sep 23;87(6):1215-1233 PMID: 26402605
  41. Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis.
    Nat Genet. 2015 Dec;47(12):1385-92 PMID: 26523775
  42. Schizophrenia risk from complex variation of complement component 4.
    Nature. 2016 Feb 11;530(7589):177-83 PMID: 26814963
  43. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.
    Nat Neurosci. 2016 Apr;19(4):571-7 PMID: 26974950
  44. Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population.
    Nat Genet. 2016 May;48(5):552-5 PMID: 26998691
  45. Analysis of protein-coding genetic variation in 60,706 humans.
    Nature. 2016 Aug 17;536(7616):285-91 PMID: 27535533
  46. Ultra-rare disruptive and damaging mutations influence educational attainment in the general population.
    Nat Neurosci. 2016 Dec;19(12):1563-1565 PMID: 27694993
  47. Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia.
    Nat Neurosci. 2016 Nov;19(11):1433-1441 PMID: 27694994
  48. Prevalence and architecture of de novo mutations in developmental disorders.
    Nature. 2017 Feb 23;542(7642):433-438 PMID: 28135719
  49. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.
    Nat Genet. 2018 Mar;50(3):381-389 PMID: 29483656
  50. 'Pfropfschizophrenie' revisited. Schizophrenia in people with mild learning disability.
    Br J Psychiatry. 1998 Aug;173:145-53 PMID: 9850227
Article Info
Journal
Nature genetics
Abbr.
Nat Genet
ISSN
1546-1718
Published
2017-08-00
Epub
2017-00-26
Pages
1167-1173
Language
English
Region
United States
NLM ID
9216904
PMCID
PMC5533219
Subset
IM
Grants
Medical Research Council · G0800270 · United Kingdom
NIMH NIH HHS · R01 MH095034 · United States
NCI NIH HHS · R01 CA133996 · United States
NCI NIH HHS · P50 CA097007 · United States
NIMH NIH HHS · R01 MH077139 · United States
NIEHS NIH HHS · R01 ES011740 · United States
NIDA NIH HHS · P50 DA019706 · United States
Medical Research Council · MR/P005748/1 · United Kingdom
NEI NIH HHS · R01 EY020483 · United States
Wellcome Trust · 100135 · United Kingdom
Medical Research Council · G0901310 · United Kingdom
NCI NIH HHS · P50 CA093459 · United States
Medical Research Council · G9815508 · United Kingdom
British Heart Foundation · RG/13/13/30194 · United Kingdom
NHGRI NIH HHS · U01 HG004446 · United States
NIMH NIH HHS · U01 MH105666 · United States
NCI NIH HHS · P01 CA089392 · United States
Medical Research Council · MR/K026992/1 · United Kingdom
Medical Research Council · MR/M008436/1 · United Kingdom
NHGRI NIH HHS · HHSN268200782096C · United States
NIMH NIH HHS · R01 MH041953 · United States
NCI NIH HHS · P50 CA084724 · United States
NIMH NIH HHS · R01 MH083094 · United States
Wellcome Trust · United Kingdom
Department of Health · PDA/02/06/016 · United Kingdom
Medical Research Council · MR/L010305/1 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]